» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-7 of 7 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
are diagnosed as Covid-19 patients by positive PCR test or by CT Scan Exclusion criteria:pregnant and (...) with Covid-19 that will be Recipient of standard national protocol drugs + Vitamin C 500mg Control Group: Patients with Covid-19 that will be Recipient of standard national protocol drugs + placebo of
IRCTID: IRCT20200324046850N5
Study aim: The effect of naproxen on the healing process of COVID-19 patients Design: This double (...) : Inclusion criteria: COVID-19 patients that have positive PCR test of nasopharyngeal sample or have positive (...) with Covid 19 (improvement of fever, chills, cough and night sweats)
IRCTID: IRCT20200324046850N3
  1. Evaluation of efficacy of pharmacotherapy treatment of COVID- 19 infection using oral Levamisole and Formoterol+Budesonide inhaler and comparison of this treatment protocol with standard national treatment of the disease
  2. Evaluation of safety and efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra on the need for intensive care unit treatment in patients with COVID-19; a randomized, multicenter, parallel groups, open label study
  3. Safety and efficacy of “Hydroxychloroquine + Azithromycin + Naproxen + Prednisolone” and “Hydroxychloroquine + Azithromycin + Naproxen” regimens in comparison with “Hydroxychloroquine + kaletra” on the need for intensive care unit treatment in patients with COVID-19; a randomized, multicenter, parallel groups, open label study
  4. Evaluation of safety and efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in hospitalized patients with COVID-19
  5. Effect of plasma of patients recovered from covid-19 versus control group on treatment of covid-19: a randomized clinical trial
  6. Comparison of vitamin D3 and N-acetylcysteine prescription in COVID19 patients and their effect on recovery process
  7. Comparison of the efficacy and safety of Atazanavir/Ritonavir plus Hydroxychloroquine regimen with Lopinavir/Ritonavir plus Hydroxychloroquine regimen in patients with moderate COVID-19, A randomized, double-blind study
  8. Evaluation of the efficacy and side effects of combination therapy of Kaletra and Hydroxychloroquine in comparison with Atazanavir / Ritonavir and Hydroxychloroquine in the treatment of patients with COVID-19
  9. The effect of vitamin C and E in the treatment and clinical course of patients with SARS-cov2 (COVID-19)
  10. The Effect of Inhalation of Thyme Oil with Standard Nationwide Medication on Respiratory Markers and Laboratory Findings in Patients with COVID-19
clinical trial. The study population includes all patients with COVID-19 referring to Abadan hospitals. All (...) severe symptoms of COVID-19 who were admitted to the infectious ward of Ayatollah Taleghani Hospital in (...) COVID-19 with severe symptoms and positive RT-PCR assay of nasopharyngeal samples Exclusion criteria
IRCTID: IRCT20200324046850N2
  1. Efficacy of Daclatasvir and Sofosbuvir (Sovodak) with Ribavirin and without Ribavirin in cirrhosis and non cirrhosis patients with HCV in Gastrointestinal and Liver Disease Research Center in 2017
  2. Safety study of Sofosbuvir 800mg and Daclatasvir 120mg in adult outpatients with COVID-19
  3. Evaluation of efficacy and safety of Sovodak (Sofosbuvir+Daclatasvir) in combination with Ribavirin for mild to moderate hospitalized Covid-19 patients compared to standard care regimen (a randomized controlled trial)
  4. A Multicentre, Quadruple-blind, Randomized, Parallel-group Study to Compare the Efficacy of Sofosbuvir and Daclatasvir vs. Placebo in the Outpatient Treatment of COVID-19 in adults
  5. Evaluation of the effect of sofosbuvir/daclatasvir in COVID-19 patients: a double-blind randomized clinical trial
  6. A prospective randomized controlled trial comparing Sovodak (Sofosbuvir plus Daclatasvir) in participants with moderate to severe Coronavirus disease (COVID-19) compared to standard of care treatment
  7. Efficacy of Daclatasvir+Sofosbuvir in patients with severe acute respiratory syndrome coronavirus (SARS-COVID-19)
  8. The effect of adding SOVODAK (sofosbuvir+daclatasvir) to the treatment protocol of COVID-19 outpatients: A Clinical Trial Study
  9. Comparison of the therapeutic effect of Sofosbuvir with Control group in outpatients with Covid-19 referred to outpatient clinics in Ahvaz
  10. Comparative assessment of the efficacy and safety of addon treatment with “Sofosbuvir-Daclatasvir”, “Lithium”,and “Trifluoprazine” to “standard of care in three groups of patients with COVID-19
criteria: COVID-19 patients that have positive PCR test COVID-19 patients that have positive by CT Scan for COVID-19. Exclusion criteria: Pregnant or breast feeding women, Patients under 18 years of age (...) laboratory findings in patients with coronary hospitalization in Abadan hospitals. Design: Clinical trial
IRCTID: IRCT20200921048783N1
inflammatory biomarkers in patients with COVID-19 Design: Clinical trial with control group, with parallel (...) performed on 88 patients with Covid-19 referring to the clinic of Razi Hospital in Ahvaz. Patients are (...) . Participants/Inclusion and exclusion criteria: Patients aged 18 to 65 years Laboratory confirmation of Covid-19
IRCTID: IRCT20200326046868N1
Ayatollah Taleghani Hospital in Abadan. The study was performed on 100 patients with COVID-19 who were (...) Study aim: Comparison of the administration of vitamin D3 and N acetylcysteine tablets in COVID-19 (...) /Inclusion and exclusion criteria: Inclusion criteria: COVID-19 patients that have positive PCR test of
IRCTID: IRCT20200324046850N1
  1. The effect of naproxen on the healing process of patients with COVID-19
  2. Acetylcysteine for the Prevention of Liver Injury in Covid-19 Intensive Care Unit Patients Under Treatment with Remdisivir: A Double-Blind, Placebo-Controlled Randomized Clinical Trial
  3. Comparison of the effect of vitamin C and N-acetyl cysteine (NAC) on improving clinical symptoms and reducing the duration of hospitalization in patients with covid-19
  4. Investigation of the efficacy and safety of colchicine In combination with standard treatment on covid-19 patients: A clinical trial
  5. Evaluation of efficacy of pharmacotherapy treatment of COVID- 19 infection using oral Levamisole and Formoterol+Budesonide inhaler and comparison of this treatment protocol with standard national treatment of the disease
  6. Evaluation of the efficacy of melatonin tablets as auxiliary medication in accelerating the improvement of the COVID-19 symptoms and clinical findings: A double-blind randomized and placebo controlled trial
  7. The effect of vitamin E and N-acetylcysteine on prevention of contrast-induced acute kidney injury after coronary catheterization in diabetic patients
  8. Evaluation of the effect of sofosbuvir/daclatasvir in COVID-19 patients: a double-blind randomized clinical trial
  9. Evaluation of N-acetylcysteine in reduction of serum total oxidative stress in comparison with placebo in chronic hemodialysis patients
  10. Effect of N - Acetylcysteine on hemoglobin and hematocrit in comparison with placebo in chronic hemodialysis patients
Study aim: Determination of the effect of sofosbuvir/daclatasvir in COVID-19 patients Design: A clinical trial with a, with parallel control group, double-blind, randomized, phase 3, and multicenter groups per 1000 patients. Settings and conduct: The study is a double-blind clinical trial. The sample
IRCTID: IRCT20200624047908N1
Loading...